Skip to main content
. 2022 Feb 27;2022:9480628. doi: 10.1155/2022/9480628

Figure 9.

Figure 9

Correlation between risk scores and chemotherapeutic drugs. (a) Cisplatin, (b) paclitaxel, (c) sorafenib, and (d) sunitinib. The results showed that sorafenib was significantly positively correlated with risk score (p < 0.05). Cisplatin, paclitaxel, and sunitinib are not correlated with risk score (p > 0.05).